Genomics Collaborative Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 35

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $14.3M

Genomics Collaborative General Information

Description

Developer of an integrated discovery platform to transform the next stage of genomic and proteomic discovery. The company provides clinical samples and develops methods for application of human genetics to target validation for drug discovery. It offers GCI platforms including GCI Discovery and Global Repository which would help in expediting drug discovery and improvements in diagnosis, prediction, prevention, and treatment of disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 99 Erie Street
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 99 Erie Street
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomics Collaborative Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 03-Jun-2004 $14.3M Completed Pre-Clinical Trials
5. Later Stage VC (Series E) 11-Nov-2002 Completed Pre-Clinical Trials
4. Later Stage VC (Series D) 12-Oct-2000 Completed Product Development
3. Later Stage VC (Series C) Completed
2. Early Stage VC (Series B) $2.2M $4.2M Completed
1. Early Stage VC (Series A) $2M $2M Completed Product Development
To view Genomics Collaborative’s complete valuation and funding history, request access »

Genomics Collaborative Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 1,543,225 $0.010000 9% $1.43 $0.11 0x $1.43 1.33%
Series A 4,200,000 $0.010000 9% $0.48 $0.08 0x $0.48 3.61%
To view Genomics Collaborative’s complete cap table history, request access »

Genomics Collaborative Patents

Genomics Collaborative Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20030022191-A1 Diagnosing mammary gland cancer in humans, obtain tissue sample, extract nucleotide sequence, amplify, electrophorese, incubate with probe, monitor pattern, detect polymorphisms Inactive 08-Jan-2001
AU-2002241821-A1 Method of detecting polymorphisms associated with breast carcinoma in mhc genes Inactive 08-Jan-2001
WO-2002053018-A2 Method of detecting polymorphisms associated with breast carcinoma in mhc genes Inactive 08-Jan-2001
WO-2002053018-A3 Method of detecting polymorphisms associated with breast carcinoma in mhc genes Inactive 08-Jan-2001
WO-2002031194-A1 Method of diagnosing and treating increased risk of death from community-acquired pneumonia associated with the a allele of the tnfα-238 polymorphism Inactive 10-Oct-2000 C12Q1/6883
To view Genomics Collaborative’s complete patent history, request access »

Genomics Collaborative Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomics Collaborative Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Flagship Pioneering Venture Capital Minority
Invesco Asset Manager Minority
Oracle Capital Partners PE/Buyout Minority
Singapore Economic Development Board Government Minority
Whitney & Company Asset Manager Minority
To view Genomics Collaborative’s complete investors history, request access »

Genomics Collaborative FAQs

  • When was Genomics Collaborative founded?

    Genomics Collaborative was founded in 1998.

  • Where is Genomics Collaborative headquartered?

    Genomics Collaborative is headquartered in Cambridge, MA.

  • What is the size of Genomics Collaborative?

    Genomics Collaborative has 35 total employees.

  • What industry is Genomics Collaborative in?

    Genomics Collaborative’s primary industry is Drug Discovery.

  • Is Genomics Collaborative a private or public company?

    Genomics Collaborative is a Private company.

  • What is the current valuation of Genomics Collaborative?

    The current valuation of Genomics Collaborative is .

  • What is Genomics Collaborative’s current revenue?

    The current revenue for Genomics Collaborative is .

  • How much funding has Genomics Collaborative raised over time?

    Genomics Collaborative has raised $57.6M.

  • Who are Genomics Collaborative’s investors?

    Flagship Pioneering, Invesco, Oracle Capital Partners, Singapore Economic Development Board, and Whitney & Company have invested in Genomics Collaborative.

  • When was Genomics Collaborative acquired?

    Genomics Collaborative was acquired on 03-Jun-2004.

  • Who acquired Genomics Collaborative?

    Genomics Collaborative was acquired by SeraCare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process